Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DR26FFBJ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,090
Award facts
- Contract value 100% obligated
- $26,090.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,090.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240 count). The delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, operates under a firm fixed-price contract structure with no set-aside designation. This award is issued pursuant to DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a broader $30.3 billion Defense Logistics Agency acquisition strategy designed to supply pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group is authorized to fulfill firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The company's demonstrated performance across numerous prior delivery orders for specialized pharmaceutical products, including oncology treatments and emergency medications, positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBJ5?
SPE2DR26FFBJ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FFBJ5 worth?
The government has obligated $26,090 on SPE2DR26FFBJ5.
Is contract SPE2DR26FFBJ5 an order under another contract?
Yes. SPE2DR26FFBJ5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBJ5 competed?
The extent of competition for SPE2DR26FFBJ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award